DRUG Projected Dividend Yield
Bright Minds Biosciences Inc ( NASDAQ : DRUG )Bright Minds Biosciences is a biotechnology company. Co. is creating chemical entities as targeted therapeutic agents for treatment of disorders where a serotonin (5-HT) receptor (either 5-HT2A, 5-HT2C or 5-HT2A/C) driven mechanism is the underlying pathology. These targeted neurocircuit disorders include neuropsychiatric, neurodegenerative, neuroinflammatory and pain disorders. Examples of these diseases include 5-HT2C disorders like pediatric epilepsies, Alzheimer's disease psychosis and dementia, 5-HT2A receptor disorders like depression and post-traumatic stress disorder, and 5-HT2A/C neuropathic pain syndromes including cluster headaches and chemotherapy induced peripheral neuropathy. 20 YEAR PERFORMANCE RESULTS |
DRUG Dividend History Detail DRUG Dividend News DRUG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |